Toosendanin is a small molecule that is capable of reprogramming macrophages and was found to improve CAR T-cell infiltration, inhibit exhaustion, and ultimately positively impact survival in GBM models when administered prior to EGFRvIII-CART. The gene discussed is CARTPT; the disease is glioblastoma.